Pharmagest Interactive SA
F:PHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmagest Interactive SA
F:PHF
|
FR |
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
|
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
SWB:RIG2
|
HU |
Wall St Price Targets
PHF Price Targets Summary
Pharmagest Interactive SA
According to Wall Street analysts, the average 1-year price target for PHF is 58.55 EUR with a low forecast of 55.79 EUR and a high forecast of 62.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHF's stock price target?
Price Target
58.55
EUR
According to Wall Street analysts, the average 1-year price target for PHF is 58.55 EUR with a low forecast of 55.79 EUR and a high forecast of 62.55 EUR.
What is the Revenue forecast for Pharmagest Interactive SA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 8%.
What is the Operating Income forecast for Pharmagest Interactive SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Pharmagest Interactive SA?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 4 years is 11%.
